Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2018

Open Access 01-12-2018 | Research article

The cutoff point of clinical chronic obstructive pulmonary disease questionnaire for more symptomatic patients

Authors: Yong Suk Jo, Sangshin Park, Deog Kyeom Kim, Chul-Gyu Yoo, Chang-Hoon Lee

Published in: BMC Pulmonary Medicine | Issue 1/2018

Login to get access

Abstract

Background

An adequate threshold for the Clinical Chronic Obstructive Pulmonary Disease (COPD) Questionnaire (CCQ) defining more symptomatic COPD patients has not been determined. We aimed to determine the efficacy of the CCQ and the appropriate CCQ threshold for more symptomatic COPD patients.

Methods

COPD patients aged > 40 years who smoked/had smoked ≥10 packs/year were prospectively enrolled over 1 year from three South Korean hospitals (n = 126). Correlations between the CCQ and St. George’s Respiratory Questionnaire (SGRQ), COPD Assessment Test (CAT), the modified Medical Round Council (mMRC) scale, lung function, and exercise capacity were evaluated. “More symptomatic patients” were those with an SGRQ score ≥ 25. Area under the receiver operating curve and classification and regression tree analyses were performed to determine the CCQ threshold equivalent to an SGRQ score ≥ 25.

Results

The CCQ significantly correlated with the SGRQ, CAT, and mMRC scale (r = 0.76, 0.69, and 0.53, respectively). A CCQ cutoff of 1.4 predicted an SGRQ score of 25 better than others. A CCQ score of 1.4 was a significant determinant of an SGRQ score ≥ 25 even after adjusting for potential confounders.

Conclusions

The CCQ was correlated with other symptom indicators, lung function, and exercise capacity. A CCQ cutoff of 1.4 agreed better than CCQ cutoff of 1.0, suggested by guideline, and this cutoff value may identify more symptomatic COPD patients well.

Trial registration

ClinicalTrials.gov Identifier: NCT02527486. Date of registration: December 19, 2014, retrospectively registered.
Literature
2.
go back to reference Ioanna T, Kocks J, Tzanakis N, Siafakas N, van der Molen T. Factors that influence disease-specific quality of life or health status in patients with COPD: a systematic review and meta-analysis of Pearson correlations. Prim Care Respir J. 2011;20(3):257–68.CrossRef Ioanna T, Kocks J, Tzanakis N, Siafakas N, van der Molen T. Factors that influence disease-specific quality of life or health status in patients with COPD: a systematic review and meta-analysis of Pearson correlations. Prim Care Respir J. 2011;20(3):257–68.CrossRef
3.
go back to reference Vincken W, Van Noord J, Greefhorst A, Bantje TA, Kesten S, Korducki L, Cornelissen P. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J. 2002;19(2):209–16.CrossRefPubMed Vincken W, Van Noord J, Greefhorst A, Bantje TA, Kesten S, Korducki L, Cornelissen P. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J. 2002;19(2):209–16.CrossRefPubMed
4.
go back to reference Jones PW, Singh D, Bateman ED, Agusti A, Lamarca R, de Miquel G, Segarra R, Caracta C, Gil EG. Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study. Eur Respir J. 2012;40(4):830–6.CrossRefPubMed Jones PW, Singh D, Bateman ED, Agusti A, Lamarca R, de Miquel G, Segarra R, Caracta C, Gil EG. Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study. Eur Respir J. 2012;40(4):830–6.CrossRefPubMed
5.
go back to reference Kerwin EM, D'Urzo AD, Gelb AF, Lakkis H, Gil EG, Caracta CF. Efficacy and safety of a 12-week treatment with twice-daily aclidinium bromide in COPD patients (ACCORD COPD I). COPD: J Chron Obstruct Pulmon Dis. 2012;9(2):90–101.CrossRef Kerwin EM, D'Urzo AD, Gelb AF, Lakkis H, Gil EG, Caracta CF. Efficacy and safety of a 12-week treatment with twice-daily aclidinium bromide in COPD patients (ACCORD COPD I). COPD: J Chron Obstruct Pulmon Dis. 2012;9(2):90–101.CrossRef
6.
go back to reference Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation: the St. George's respiratory questionnaire. Am Rev Respir Dis. 1992;145(6):1321–7.CrossRefPubMed Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation: the St. George's respiratory questionnaire. Am Rev Respir Dis. 1992;145(6):1321–7.CrossRefPubMed
7.
go back to reference Ferrer M, Alonso J, Prieto L, Plaza V, Monsó E, Marrades R, Aguar M, Khalaf A, Antó J. Validity and reliability of the St George's respiratory questionnaire after adaptation to a different language and culture: the Spanish example. Eur Respir J. 1996;9(6):1160–6.CrossRefPubMed Ferrer M, Alonso J, Prieto L, Plaza V, Monsó E, Marrades R, Aguar M, Khalaf A, Antó J. Validity and reliability of the St George's respiratory questionnaire after adaptation to a different language and culture: the Spanish example. Eur Respir J. 1996;9(6):1160–6.CrossRefPubMed
8.
go back to reference Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, Perez T, Cataluña JS, van der Molen T, Adamek L. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J. 2011;38(1):29–35.CrossRefPubMed Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, Perez T, Cataluña JS, van der Molen T, Adamek L. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J. 2011;38(1):29–35.CrossRefPubMed
9.
go back to reference Jones P, Harding G, Berry P, Wiklund I, Chen W, Leidy NK. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–54.CrossRefPubMed Jones P, Harding G, Berry P, Wiklund I, Chen W, Leidy NK. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–54.CrossRefPubMed
10.
go back to reference Rieger-Reyes C, García-Tirado FJ, Rubio-Galán FJ, Marín-Trigo JM. Classification of chronic obstructive pulmonary disease severity according to the new Global initiative for chronic obstructive lung disease 2011 guidelines: COPD assessment test versus modified Medical Research Council scale. Archivos de Bronconeumología (English Edition). 2014;50(4):129–34.CrossRef Rieger-Reyes C, García-Tirado FJ, Rubio-Galán FJ, Marín-Trigo JM. Classification of chronic obstructive pulmonary disease severity according to the new Global initiative for chronic obstructive lung disease 2011 guidelines: COPD assessment test versus modified Medical Research Council scale. Archivos de Bronconeumología (English Edition). 2014;50(4):129–34.CrossRef
11.
go back to reference Jones PW, Nadeau G, Small M, Adamek L. Characteristics of a COPD population categorised using the GOLD framework by health status and exacerbations. Respir Med. 2014;108(1):129–35.CrossRefPubMed Jones PW, Nadeau G, Small M, Adamek L. Characteristics of a COPD population categorised using the GOLD framework by health status and exacerbations. Respir Med. 2014;108(1):129–35.CrossRefPubMed
12.
go back to reference Han J, Dai L, Zhong N, Young D. Breathlessness or health status in chronic obstructive pulmonary disease: the impact of different definitions. COPD: J Chron Obstruct Pulmon Dis. 2015;12(2):115–25.CrossRef Han J, Dai L, Zhong N, Young D. Breathlessness or health status in chronic obstructive pulmonary disease: the impact of different definitions. COPD: J Chron Obstruct Pulmon Dis. 2015;12(2):115–25.CrossRef
13.
go back to reference Van der Molen T, Willemse BW, Schokker S, Ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the clinical COPD questionnaire. Health Qual Life Outcomes. 2003;1(1):1.CrossRef Van der Molen T, Willemse BW, Schokker S, Ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the clinical COPD questionnaire. Health Qual Life Outcomes. 2003;1(1):1.CrossRef
14.
go back to reference Sundh J, Ställberg B, Lisspers K, Kämpe M, Janson C, Montgomery S. Comparison of the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ) in a clinical population. COPD: J Chron Obstruct Pulmon Dis. 2016;13(1):57–65. Sundh J, Ställberg B, Lisspers K, Kämpe M, Janson C, Montgomery S. Comparison of the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ) in a clinical population. COPD: J Chron Obstruct Pulmon Dis. 2016;13(1):57–65.
15.
go back to reference Lin W-C, Huang T-Y, Liu C-Y, Yeh M-L, Yu C-H, Hwang S-L. Validation of the clinical COPD questionnaire in Taiwan. COPD: J Chron Obstruct Pulmon Dis. 2016;13(3):360–6. Lin W-C, Huang T-Y, Liu C-Y, Yeh M-L, Yu C-H, Hwang S-L. Validation of the clinical COPD questionnaire in Taiwan. COPD: J Chron Obstruct Pulmon Dis. 2016;13(3):360–6.
16.
go back to reference American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique--1995 update. Am J Respir Crit Care Med. 1995;152(6 Pt 1):2185–98. American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique--1995 update. Am J Respir Crit Care Med. 1995;152(6 Pt 1):2185–98.
17.
go back to reference Wanger J, Clausen J, Coates A, Pedersen O, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, Van Der Grinten C. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26(3):511.CrossRefPubMed Wanger J, Clausen J, Coates A, Pedersen O, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, Van Der Grinten C. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26(3):511.CrossRefPubMed
18.
go back to reference Morris JF, Koski A, Johnson LC. Spirometric standards for healthy nonsmoking adults 1–3. Am Rev Respir Dis. 1971;103(1):57–67.PubMed Morris JF, Koski A, Johnson LC. Spirometric standards for healthy nonsmoking adults 1–3. Am Rev Respir Dis. 1971;103(1):57–67.PubMed
19.
go back to reference LEE CH, LEE JY, JANG EJ, PARK KY, HAN HW. New predictive equations for spirometric reference values and comparison with Morris equation in a Korean population. Respirology. 2008;13(3):365–71.CrossRefPubMed LEE CH, LEE JY, JANG EJ, PARK KY, HAN HW. New predictive equations for spirometric reference values and comparison with Morris equation in a Korean population. Respirology. 2008;13(3):365–71.CrossRefPubMed
20.
go back to reference Ferris BG. Epidemiology standardization project (American Thoracic Society). Am Rev Respir Dis. 1978;118(6 Pt 2):1.PubMed Ferris BG. Epidemiology standardization project (American Thoracic Society). Am Rev Respir Dis. 1978;118(6 Pt 2):1.PubMed
21.
go back to reference Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. CHEST J. 1988;93(3):580–6.CrossRef Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. CHEST J. 1988;93(3):580–6.CrossRef
22.
go back to reference Kon SS, Canavan JL, Jones SE, Nolan CM, Clark AL, Dickson MJ, Haselden BM, Polkey MI, Man WD. Minimum clinically important difference for the COPD assessment test: a prospective analysis. Lancet Respir Med. 2014;2(3):195–203.CrossRefPubMed Kon SS, Canavan JL, Jones SE, Nolan CM, Clark AL, Dickson MJ, Haselden BM, Polkey MI, Man WD. Minimum clinically important difference for the COPD assessment test: a prospective analysis. Lancet Respir Med. 2014;2(3):195–203.CrossRefPubMed
24.
go back to reference Laboratories ACoPSfCPF. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111.CrossRef Laboratories ACoPSfCPF. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111.CrossRef
25.
go back to reference Canavan JL, Dilaver D, Clark AL, Jones SE, Nolan CM, Kon SS, Man WDC. Clinical COPD questionnaire in patients with chronic respiratory disease. Respirology. 2014;19(7):1006–12.CrossRefPubMed Canavan JL, Dilaver D, Clark AL, Jones SE, Nolan CM, Kon SS, Man WDC. Clinical COPD questionnaire in patients with chronic respiratory disease. Respirology. 2014;19(7):1006–12.CrossRefPubMed
27.
go back to reference Tsiligianni IG, Alma HJ, de Jong C, Jelusic D, Wittmann M, Schuler M, Schultz K, Kollen BJ, van der Molen T, Kocks JW. Investigating sensitivity, specificity, and area under the curve of the clinical COPD questionnaire, COPD assessment test, and modified Medical Research Council scale according to GOLD using St George's respiratory questionnaire cutoff 25 (and 20) as reference. Int J Chron Obstruct Pulmon Dis. 2016;11:1045–52.CrossRefPubMedPubMedCentral Tsiligianni IG, Alma HJ, de Jong C, Jelusic D, Wittmann M, Schuler M, Schultz K, Kollen BJ, van der Molen T, Kocks JW. Investigating sensitivity, specificity, and area under the curve of the clinical COPD questionnaire, COPD assessment test, and modified Medical Research Council scale according to GOLD using St George's respiratory questionnaire cutoff 25 (and 20) as reference. Int J Chron Obstruct Pulmon Dis. 2016;11:1045–52.CrossRefPubMedPubMedCentral
28.
go back to reference Kon SS, Dilaver D, Mittal M, Nolan CM, Clark AL, Canavan JL, Jones SE, Polkey MI, Man WD. The clinical COPD questionnaire: response to pulmonary rehabilitation and minimal clinically important difference. Thorax. 2014;69(9):793–8.CrossRefPubMed Kon SS, Dilaver D, Mittal M, Nolan CM, Clark AL, Canavan JL, Jones SE, Polkey MI, Man WD. The clinical COPD questionnaire: response to pulmonary rehabilitation and minimal clinically important difference. Thorax. 2014;69(9):793–8.CrossRefPubMed
29.
go back to reference Kocks JW, Tuinenga M, Uil S, Van den Berg J, Stahl E, Van der Molen T. Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir Res. 2006;7(62):1465–993. Kocks JW, Tuinenga M, Uil S, Van den Berg J, Stahl E, Van der Molen T. Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir Res. 2006;7(62):1465–993.
30.
go back to reference Lee C-H, Lee J, Park YS, Lee S-M, Yim J-J, Kim YW, Han SK, Yoo C-G. Chronic obstructive pulmonary disease (COPD) assessment test scores corresponding to modified Medical Research Council grades among COPD patients. Korean J Intern Med. 2015;30(5):629.CrossRefPubMedPubMedCentral Lee C-H, Lee J, Park YS, Lee S-M, Yim J-J, Kim YW, Han SK, Yoo C-G. Chronic obstructive pulmonary disease (COPD) assessment test scores corresponding to modified Medical Research Council grades among COPD patients. Korean J Intern Med. 2015;30(5):629.CrossRefPubMedPubMedCentral
31.
go back to reference Pillai AP, Turner AM, Stockley RA. Global initiative for chronic obstructive lung disease 2011 symptom/risk assessment in α1-antitrypsin deficiency. CHEST J. 2013;144(4):1152–62.CrossRef Pillai AP, Turner AM, Stockley RA. Global initiative for chronic obstructive lung disease 2011 symptom/risk assessment in α1-antitrypsin deficiency. CHEST J. 2013;144(4):1152–62.CrossRef
32.
go back to reference Karloh M, Mayer AF, Maurici R, Pizzichini MM, Jones PW, Pizzichini E. The COPD assessment test: what do we know so far?: a systematic review and meta-analysis about clinical outcomes prediction and classification of patients into GOLD stages. CHEST J. 2016;149(2):413–25.CrossRef Karloh M, Mayer AF, Maurici R, Pizzichini MM, Jones PW, Pizzichini E. The COPD assessment test: what do we know so far?: a systematic review and meta-analysis about clinical outcomes prediction and classification of patients into GOLD stages. CHEST J. 2016;149(2):413–25.CrossRef
Metadata
Title
The cutoff point of clinical chronic obstructive pulmonary disease questionnaire for more symptomatic patients
Authors
Yong Suk Jo
Sangshin Park
Deog Kyeom Kim
Chul-Gyu Yoo
Chang-Hoon Lee
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2018
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-018-0601-0

Other articles of this Issue 1/2018

BMC Pulmonary Medicine 1/2018 Go to the issue